You are here: Industry Insights > SARS-CoV-2

News List

BOLD-100 significantly outperforms remdesivir head-to-head in SARS-CoV-2 model pharmaceutical-business-review
August 20, 2020
Bold Therapeutics, a clinical-stage biopharmaceutical company, recently generated additional data supporting rapid clinical development of BOLD-100 as a novel antiviral.
Ingenza Achieves COVID-19 Vax Milestone contractpharma
August 20, 2020
Prototype vaccine elicits a powerful immunogenic response in mouse studies.
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19 expresspharma
August 19, 2020
The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies.
Researchers design and test protein that may lead to COVID-19 therapeutic worldpharmanews
August 18, 2020
A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.
Global Virus Network Reports: Renowned Doherty Institute In Australia Independently Verifies Earlier Findings That An Antimicrobial Technology Eradicates SARS-CoV-2 On Surfaces For More Than Six Weeks prnewswire
August 17, 2020
The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 33 countries, announced that the Peter Doherty Institute for Infection and ...
Phase III trial to study NT-300 as COVID-19 treatment initiated europeanpharmaceuticalreview
August 17, 2020
A Phase III trial to investigate NT-300 (nitazoxanide extended-release tablets) as a treatment for mild or moderate COVID-19 has begun.
Virus uses ‘decoy’ strategy to evade immune system: Otago researchers expresspharma
August 17, 2020
The research demonstrates another manner in which viruses are capable of hijacking infected cells and alerts scientists to the novel mechanism of viral transmission, say scientists.
Atrimed Pharma claims breakthrough in molecule research for COVID-19 cure expresspharma
August 17, 2020
Reportedly, three of its samples tested positive against SARS-CoV-2 in an ICMR-designated laboratory.
Scientists leverage AI to find COVID-19 drug candidates expresspharma
August 14, 2020
They identified the best-in-class hits for the 65 human proteins that interact with SARS-CoV-2 proteins.
Scientists identify hundreds of drug candidates to treat COVID-19 worldpharmanews
August 13, 2020
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page